Granich RM - Search Results

1

How can mathematical models advance tuberculosis control in high HIV prevalence settings?

Houben RM, Dowdy DW, Vassall A, Cohen T, Nicol MP, Granich RM, Shea JE, Eckhoff P, Dye C, Kimerling ME, White RG; TB MAC TB-HIV meeting participants. Houben RM, et al. Among authors: granich rm. Int J Tuberc Lung Dis. 2014 May;18(5):509-14. doi: 10.5588/ijtld.13.0773. Int J Tuberc Lung Dis. 2014. PMID: 24903784 Free PMC article. Review.

2

Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.

Suthar AB, Klinkenberg E, Ramsay A, Garg N, Bennett R, Towle M, Sitienei J, Smyth C, Daniels C, Baggaley R, Gunneberg C, Williams B, Getahun H, van Gorkom J, Granich RM. Suthar AB, et al. Among authors: granich rm. Int J Tuberc Lung Dis. 2012 Apr;16(4):430-6. doi: 10.5588/ijtld.11.0480. Int J Tuberc Lung Dis. 2012. PMID: 22640510

3

Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings.

Lawn SD, Ayles H, Egwaga S, Williams B, Mukadi YD, Santos Filho ED, Godfrey-Faussett P, Granich RM, Harries AD. Lawn SD, et al. Among authors: granich rm. Int J Tuberc Lung Dis. 2011 Mar;15(3):287-95. Int J Tuberc Lung Dis. 2011. PMID: 21333094

4

Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.

Gupta S, Abimbola T, Date A, Suthar AB, Bennett R, Sangrujee N, Granich R. Gupta S, et al. Int J Tuberc Lung Dis. 2014 Oct;18(10):1159-65. doi: 10.5588/ijtld.13.0571. Int J Tuberc Lung Dis. 2014. PMID: 25216828 Free PMC article.

5

Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?

Loeliger A, Suthar AB, Ripin D, Glaziou P, O'Brien M, Renaud-Thery F, Crowley S, Williams B, Ridzon R, Granich R, Gilks C. Loeliger A, et al. Int J Tuberc Lung Dis. 2012 Jan;16(1):6-15. doi: 10.5588/ijtld.10.0626. Epub 2011 Aug 3. Int J Tuberc Lung Dis. 2012. PMID: 21819645 Review.

6

Highly active antiretroviral treatment for the prevention of HIV transmission.

Granich R, Crowley S, Vitoria M, Lo YR, Souteyrand Y, Dye C, Gilks C, Guerma T, De Cock KM, Williams B. Granich R, et al. J Int AIDS Soc. 2010 Jan 12;13:1. doi: 10.1186/1758-2652-13-1. J Int AIDS Soc. 2010. PMID: 20205768 Free PMC article.

7

Antiretroviral therapy for tuberculosis control in nine African countries.

Williams BG, Granich R, De Cock KM, Glaziou P, Sharma A, Dye C. Williams BG, et al. Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19485-9. doi: 10.1073/pnas.1005660107. Epub 2010 Oct 25. Proc Natl Acad Sci U S A. 2010. PMID: 20974976 Free PMC article.

8

Benefits of combined preventive therapy with co-trimoxazole and isoniazid in adults living with HIV: time to consider a fixed-dose, single tablet coformulation.

Harries AD, Lawn SD, Suthar AB, Granich R. Harries AD, et al. Lancet Infect Dis. 2015 Dec;15(12):1492-6. doi: 10.1016/S1473-3099(15)00242-X. Epub 2015 Oct 27. Lancet Infect Dis. 2015. PMID: 26515525 Review.

9

HIV treatment: time to lean forward.

Granich R, Williams B. Granich R, et al. Lancet. 2016 Jan 2;387(10013):27. doi: 10.1016/S0140-6736(15)01293-3. Lancet. 2016. PMID: 26766341 No abstract available.

10

Treatment as prevention trials and ending AIDS: what do we know, when did we know it, and what do we do now?

Granich R, Williams BG. Granich R, et al. Curr Opin HIV AIDS. 2019 Nov;14(6):514-520. doi: 10.1097/COH.0000000000000582. Curr Opin HIV AIDS. 2019. PMID: 31567399 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters